Tingley Whittemore's Form 4 filing
Tenaya Therapeutics, Inc. (TNYA) · filed Aug 17, 2026
- Accession no.
- 0001193125-26-354517
- Filed
- Aug 17, 2026, 8:49 PM ET
- Trade date
- Aug 17, 2026
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions and 0 derivative transactions. Open-market sales total $5.27K. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Tingley WhittemoreCIK 0001868494 | Officer (Chief Medical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 17, 2026 | Common Stock | SSaleDisposed | −1,637 | $0.7098 | −$1,161.94 | 219,860 | Direct | |
| Aug 17, 2026 | Common Stock | SSaleDisposed | −1,637 | $0.7098 | −$1,161.94 | 218,223 | Direct | |
| Aug 17, 2026 | Common Stock | SSaleDisposed | −1,871 | $0.7098 | −$1,328.04 | 216,352 | Direct | |
| Aug 17, 2026 | Common Stock | SSaleDisposed | −2,279 | $0.7098 | −$1,617.63 | 214,073 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.